Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $2.03 billion
- Book Value:
- Revenue TTM:
- $2.97 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $471.63 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Adapthealth Corp had its IPO on 2018-05-24 under the ticker symbol AHCO.
The company operates in the Healthcare sector and Medical Devices industry. Adapthealth Corp has a staff strength of 10,900 employees.
Shares of Adapthealth Corp opened at $10.74 at the start of the last trading session i.e. 2023-06-02.
The stocks traded within a range of $10.33 - $10.74, and closed at $10.5.
This is a -0.57% slip from the previous day's closing price.
A total volume of 1,200,778 shares were traded at the close of the day’s session.
In the last one week, shares of Adapthealth Corp have slipped by -4.02%.
Adapthealth Corp's Key Ratios
Adapthealth Corp has a market cap of $2.03 billion, indicating a price to book ratio of 1.2577 and a price to sales ratio of 0.9329.
In the last 12-months Adapthealth Corp’s revenue was $2.97 billion with a gross profit of $471.63 million and an EBITDA of $567.29 million. The EBITDA ratio measures Adapthealth Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Adapthealth Corp’s operating margin was 7.28% while its return on assets stood at 2.58% with a return of equity of 3.46%.
In Q4, Adapthealth Corp’s quarterly earnings growth was a negative -45.3% while revenue growth was a positive 9.5%.
Adapthealth Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.33 per share while it has a forward price to earnings multiple of 16.835 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Adapthealth Corp’s profitability.
Adapthealth Corp stock is trading at a EV to sales ratio of 1.7548 and a EV to EBITDA ratio of 8.8154. Its price to sales ratio in the trailing 12-months stood at 0.9329.
Adapthealth Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $5.22 billion
- Total Liabilities
- $456.21 million
- Operating Cash Flow
- Capital Expenditure
- $142.91 million
- Dividend Payout Ratio
Adapthealth Corp ended 2023 with $5.22 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $5.22 billion while shareholder equity stood at $2.16 billion.
Adapthealth Corp ended 2023 with $0 in deferred long-term liabilities, $456.21 million in other current liabilities, in common stock, $26.30 million in retained earnings and $3.55 billion in goodwill. Its cash balance stood at $46.27 million and cash and short-term investments were $46.27 million. The company’s total short-term debt was $67,212,000 while long-term debt stood at $2.15 billion.
Adapthealth Corp’s total current assets stands at $585.31 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $359.15 million compared to accounts payable of $337.50 million and inventory worth $127.75 million.
In 2023, Adapthealth Corp's operating cash flow was $0 while its capital expenditure stood at $142.91 million.
Comparatively, Adapthealth Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Adapthealth Corp stock is currently trading at $10.5 per share. It touched a 52-week high of $27.48 and a 52-week low of $27.48. Analysts tracking the stock have a 12-month average target price of $23.44.
Its 50-day moving average was $11.71 and 200-day moving average was $17.96 The short ratio stood at 13.89 indicating a short percent outstanding of 0%.
Around 2338.5% of the company’s stock are held by insiders while 8457.8% are held by institutions.
Frequently Asked Questions About Adapthealth Corp
Similar Industry Stocks (Medical Devices)
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.